We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70
Avg Time Held
12 quarters
Top 10 Avg Time Held
12 quarters
Top 20 Avg Time Held
10.4 quarters

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
IJH icon
951
iShares Core S&P Mid-Cap ETF
IJH
$122B
$432K ﹤0.01%
+7,379
New +$434K
2024 Q2
0 quarters
ARWR icon
952
Arrowhead Research
ARWR
$8.36B
$428K ﹤0.01%
16,465
-825
-5% -$20.3K
2020 Q2
16 quarters
FBP icon
953
First Bancorp
FBP
$4.06B
$427K ﹤0.01%
23,361
+2,086
+10% +$36.5K
2021 Q2
12 quarters
ASB icon
954
Associated Banc-Corp
ASB
$5.37B
$426K ﹤0.01%
20,119
-1,390
-6% -$29.3K
2020 Q2
16 quarters
PCH icon
955
DELISTED
PotlatchDeltic
PCH
$423K ﹤0.01%
10,742
-651
-6% -$27.6K
2020 Q2
16 quarters
FIVN icon
956
FIVE9
FIVN
$2.58B
$421K ﹤0.01%
9,554
+153
+2% +$7.95K
2020 Q2
16 quarters
NSIT icon
957
Insight Enterprises
NSIT
$5.02B
$419K ﹤0.01%
2,114
+52
+3% +$10.1K
2023 Q1
5 quarters
BLKB icon
958
Blackbaud
BLKB
$2.2B
$419K ﹤0.01%
5,500
-634
-10% -$48.8K
2020 Q2
16 quarters
CUZ icon
959
Cousins Properties
CUZ
$4.5B
$418K ﹤0.01%
18,044
-3,315
-16% -$76.3K
2020 Q2
16 quarters
NWE icon
960
NorthWestern Energy
NWE
$4.53B
$417K ﹤0.01%
8,327
-511
-6% -$25.8K
2020 Q2
16 quarters
IBOC icon
961
International Bancshares
IBOC
$4.19B
$415K ﹤0.01%
7,255
-444
-6% -$25K
2020 Q4
14 quarters
FTI icon
962
TechnipFMC
FTI
$27.6B
$409K ﹤0.01%
15,642
-314
-2% -$8.09K
2023 Q2
4 quarters
RDN icon
963
Radian Group
RDN
$4.4B
$408K ﹤0.01%
13,121
+321
+3% +$9.91K
2023 Q1
5 quarters
SPXC icon
964
SPX Corp
SPXC
$8.47B
$407K ﹤0.01%
2,864
+189
+7% +$24.9K
2023 Q2
4 quarters
CNO icon
965
CNO Financial Group
CNO
$4.93B
$406K ﹤0.01%
14,640
-1,215
-8% -$33.2K
2020 Q2
16 quarters
MLI icon
966
Mueller Industries
MLI
$13.5B
$406K ﹤0.01%
14,246
+604
+4% +$16.9K
2023 Q1
5 quarters
VLY icon
967
Valley National Bancorp
VLY
$6.86B
$405K ﹤0.01%
58,024
-3,681
-6% -$26.9K
2020 Q2
16 quarters
GMS icon
968
DELISTED
GMS Inc
GMS
$404K ﹤0.01%
5,017
-17
-0.3% -$1.57K
2023 Q2
4 quarters
COTY icon
969
Coty
COTY
$2.56B
$404K ﹤0.01%
40,302
-4,471
-10% -$47.9K
2020 Q2
16 quarters
GTM icon
970
ZoomInfo Technologies
GTM
$1.15B
$404K ﹤0.01%
31,621
-17,317
-35% -$242K
2022 Q2
8 quarters
BYD icon
971
Boyd Gaming
BYD
$5.02B
$403K ﹤0.01%
7,315
-1,033
-12% -$59K
2020 Q2
16 quarters
ALKS icon
972
Alkermes
ALKS
$6.72B
$402K ﹤0.01%
16,694
-261
-2% -$6.4K
2022 Q1
9 quarters
LIVN icon
973
LivaNova
LIVN
$4.2B
$401K ﹤0.01%
7,314
-433
-6% -$24.7K
2020 Q2
16 quarters
KRC icon
974
Kilroy Realty
KRC
$3.96B
$396K ﹤0.01%
12,708
-2,001
-14% -$66.5K
2020 Q2
16 quarters
VC icon
975
Visteon
VC
$2.3B
$396K ﹤0.01%
3,712
-254
-6% -$28.1K
2020 Q2
16 quarters

Similar funds

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.